Mediar Therapeutics

Series-B
mediartx.com Biotech & Healthcare Boston, United States Founded 2018 11–50 employees
Total Funding $181M
Latest Round $76M Series-B
Last Announced Jan 7, 2026
Investors 15 Backers
Decision Makers Profile Active

About Mediar Therapeutics

New perspective. Novel targets. Clinical trials. The myofibroblast is responsible for depositing collagen, extracellular matrix, and maintaining the pro-fibrotic micro-environment in organ systems. By deactivating the myofibroblast, we hope to slow fibrosis and possibly reverse it.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Boston, United States
Year Founded 2018
Team Size 11–50 employees
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website mediartx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @david_lagares
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $76,000,000 · Series-B

    Backed by Amplitude Venture Capital

  2. Capital Raise

    Raised $105,000,000 · Series-A

    Backed by Novartis Venture Fund

  3. Milestone

    Company founded

    Boston, United States

Investors & Backers

15
Amplitude Venture Capital
Lead
Novartis Venture Fund
Lead
Alexandria Real Estate Equities
Asahi Kasei Pharma
Bristol-Myers Squibb
Eli Lilly & Company Foundation
Gimv
Intermediate Capital Group
Longwood Fund
Mass General Brigham Ventures
Mission BioCapital
Ono Venture Investment
Pfizer Venture Investments
Pureos Bioventures
Sofinnova Partners

Funding History

2 Rounds
Series-B equity · Jan 7, 2026

Round backers: Amplitude Venture Capital

Series-A equity · Mar 15, 2023

Round backers: Novartis Venture Fund

$105,000,000 mediartx.com

Founders & Leadership

6

David Lagares

Founder

Work email & phone locked Unlock →

Jeffrey Bornstein

Chief Medical Officer

Work email & phone locked Unlock →

Meredith Fisher

Founder

Work email & phone locked Unlock →

Paul Yaworsky

Founder

Work email & phone locked Unlock →

Rahul Ballal

CEO

Work email & phone locked Unlock →

Simon Sturge

Executive chairman

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts